Nuvectis Pharma, Inc.NVCTNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank0
Studio
Year-over-Year Change

Operating cash flow minus capital expenditures

Latest
$-16.01M
↓ 43% vs avg
Percentile
P0
Near historical low
Streak
1 yr
Consecutive declineContracting
Average
$-11.21M
Historical baseline
PeriodValueYoY Change
2025$-16.01M-30.7%
2024$-12.25M+23.2%
2023$-15.95M-17.7%
2022$-13.56M-42.7%
2021$-9.50M-
2020$0.00-